Pharmafile Logo
Pharmafocus logo
Advanced Search
Andrew Lansley

First GP consortia named

December 9, 2010
Sales and Marketing Lansley, NHS, consortia, reforms

The first consortia of GPs who will spearhead England’s healthcare reforms have been unveiled. A total of 52 consortia from …

News
Blog footer

Digital Pharma: AZ launches its first UK iPhone app

December 8, 2010
Medical Communications Apple, AstraZeneca, Digital Pharma blog, apps, ipad, iphone

AstraZeneca has launched an iPhone app to provide UK healthcare professionals with information on genetic tests for lung cancer. The …

News

GSK acquires China’s Nanjing MeiRui Pharma for $70m

December 8, 2010
Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing

GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …

News

William Vickery joins Hybrigenics

December 8, 2010
Research and Development Hybrigenics, William Vickery, appointment, research and development

Paris-based biopharmaceutical company Hybrigenics has appointed William Vickery to the newly-created position of head of corporate and business development. He …

Appointment

Astellas signs stem cell partnership in liver disease

December 8, 2010
Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine

Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …

News

Out-of-hour procedures for clinical trials

December 8, 2010
Research and Development GCP, Good Clinical Practice, Guy’s and St Thomas’ NHS Foundation Trust, Katherine Kennedy, clinical trials, trial safety

When a clinical trial subject is involved in a medical emergency, the hospital team need rapid access to information about …

Feature
Avastin packs

NICE no for Avastin in breast cancer

December 8, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta

NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …

News

Contract research news in brief

December 8, 2010
Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations

Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …

News

WPP launches Healix Digital Health

December 7, 2010
Medical Communications Grey Healthcare, VML, WPP, digital marketing, digital marketing agency

A new digital healthcare agency, Healix Digital Health, has been launched by two companies within the WPP group. Grey Healthcare …

News

Trial hitch for Pfizer’s leukaemia drug submission plans

December 7, 2010
Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia

Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …

News

WikiLeaks defends decision to publish critical facilities list

December 7, 2010
Manufacturing and Production WikiLeaks, pharma manufacturing, security

Pharmaceutical facilities have featured prominently in in the latest batch of secret US embassy cables made public by WikiLeaks. The …

News

Takeda and Baxter make pandemic flu vaccine plans for Japan

December 7, 2010
Manufacturing and Production Takeda, baxter, pharma manufacturing, vaccine manufacturing, vaccines

Takeda has made another move into the vaccines sector with the expansion of a deal with Baxter International for the …

News

AZ’s Brilique approved in Europe

December 7, 2010
Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor

European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …

News

Pharma manufacturing news in brief

December 7, 2010
Manufacturing and Production A5 Laboratories, Adamis Pharmaceuticals, Beximco Pharmaceuticals, Caraco Pharmaceutical, Genethon BioProd, Jiangsu Yanshen Biological Technology, Viva Pharmaceuticals, contract manufacturing, gene therapy

Our round-up of manufacturing updates includes the world’s first dedicated gene therapy facility, hefty fines for a Chinese drugmaker plus …

News
EU flag

EU regulators launch fresh raids on pharma

December 7, 2010
Sales and Marketing AstraZeneca, European Commission, Losec, Nexium, Nycomed, Pantazol, Ratiopharm, antitrust investigation, esomeprazole, pantoprazole

Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …

News

Laura Lane joins Black Swan

December 6, 2010
Sales and Marketing Black Swan Analysis, Laura Lane, appointment, sales and marketing

Black Swan Analysis has appointed Dr Laura Lane to its Analysis and Forecasting team.Laura brings with her a strong scientific …

Appointment

Roche’s MabThera successor shows phase II promise

December 6, 2010
Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia

The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …

News

Surprise exit for Pfizer chief executive Jeffrey Kindler

December 6, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Jeffrey Kindler, Lipitor, Pfizer, Wyeth, executive succession

Pfizer’s chief executive Jeffrey Kindler has unexpectedly stepped down, saying his time at the helm of the world’s largest pharmaceutical …

News
Roche's MabThera

NICE recommends MabThera for non-Hodgkin’s lymphoma

December 6, 2010
Sales and Marketing MabThera, NICE, Rituxan, Roche, non-Hodgkin’s lymphoma, rituximab

NICE has given a preliminary green-light to Roche’s MabThera for use as a maintenance therapy for non-Hodgkin’s lymphoma. The Institute’s …

News

A mature approach to relationships with pharma’s customers

December 6, 2010
Sales and Marketing MSI, Paul Stuart Kregor, franchise management, pharma marketing

Commercial managers who are responsible for a number of brands face a constant challenge in choosing where across the franchise …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026